ProfileGDS5822 / ILMN_2728300
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 45% 54% 46% 50% 47% 58% 30% 46% 20% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 119.845
GSM1276600PDAC Late Ablation Control 226.254
GSM1276601PDAC Late Ablation Control 317.846
GSM1276602PDAC Late Ablation 119.450
GSM1276603PDAC Late Ablation 221.447
GSM1276604PDAC Late Ablation 330.558
GSM1303940PDAC Late Ablation_anti-CTLA4 115.430
GSM1303941PDAC Late Ablation_anti-CTLA4 222.646
GSM1303942PDAC Late Ablation_anti-CTLA4 310.520